Cigna Group (NYSE:CI) Insider Nicole S. Jones Sells 28,526 Shares

Key Points

• Nicole Jones, an insider at Cigna Group, sold 28,526 shares of the company at an average price of $300, totaling approximately $8.56 million, resulting in a 52.66% decrease in her position.
• Cigna Group reported Q2 earnings of $7.20 EPS, exceeding analysts' expectations, and revenue of $67.13 billion, marking an 11% year-over-year increase.
• The company declared a quarterly dividend of $1.51 per share, with a dividend yield of 2.0%, to be paid on September 18th to stockholders of record.

Cigna Group (NYSE:CI - Get Free Report) insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares of the company's stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Cigna Group Price Performance

Shares of CI traded up $4.0950 during trading hours on Friday, reaching $305.0450. 677,817 shares of the stock traded hands, compared to its average volume of 1,844,648. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The company has a market cap of $81.43 billion, a P/E ratio of 16.64, a price-to-earnings-growth ratio of 0.89 and a beta of 0.47. The company's 50-day moving average price is $301.16 and its two-hundred day moving average price is $311.31. Cigna Group has a 52-week low of $256.89 and a 52-week high of $370.83.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the previous year, the firm posted $6.72 EPS. The business's quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group's dividend payout ratio is presently 32.97%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Flaharty Asset Management LLC purchased a new position in Cigna Group in the first quarter valued at $28,000. 1248 Management LLC purchased a new position in Cigna Group in the first quarter valued at $29,000. Solstein Capital LLC purchased a new position in Cigna Group in the second quarter valued at $29,000. Activest Wealth Management increased its holdings in Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after buying an additional 72 shares in the last quarter. Finally, Chilton Capital Management LLC purchased a new position in Cigna Group in the second quarter valued at $30,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Wall Street Zen downgraded shares of Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Piper Sandler upped their price target on shares of Cigna Group from $348.00 to $374.00 and gave the company an "overweight" rating in a report on Monday, May 5th. Guggenheim restated a "buy" rating and issued a $350.00 target price (down from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Royal Bank Of Canada restated an "outperform" rating and issued a $371.00 target price on shares of Cigna Group in a research note on Thursday, June 26th. Finally, Wells Fargo & Company dropped their target price on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, Cigna Group currently has a consensus rating of "Buy" and a consensus price target of $374.82.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.